The DOI matches its Crossref record; 295 of the 295 references it cites were found in a registry or an index.
The Emerging Role of the Endocannabinoid System in Endocrine Regulation and Energy Balance
Abstract
During the last few years, the endocannabinoid system has emerged as a highly relevant topic in the scientific community. Many different regulatory actions have been attributed to endocannabinoids, and their involvement in several pathophysiological conditions is under intense scrutiny. Cannabinoid receptors, named CB1 receptor and CB2 receptor, first discovered as the molecular targets of the psychotropic component of the plant Cannabis sativa, participate in the physiological modulation of many central and peripheral functions. CB2 receptor is mainly expressed in immune cells, whereas CB1 receptor is the most abundant G protein-coupled receptor expressed in the brain. CB1 receptor is expressed in the hypothalamus and the pituitary gland, and its activation is known to modulate all the endocrine hypothalamic-peripheral endocrine axes. An increasing amount of data highlights the role of the system in the stress response by influencing the hypothalamic-pituitary-adrenal axis and in the control of reproduction by modifying gonadotropin release, fertility, and sexual behavior. The ability of the endocannabinoid system to control appetite, food intake, and energy balance has recently received great attention, particularly in the light of the different modes of action underlying these functions. The endocannabinoid system modulates rewarding properties of food by acting at specific mesolimbic areas in the brain. In the hypothalamus, CB1 receptor and endocannabinoids are integrated components of the networks controlling appetite and food intake. Interestingly, the endocannabinoid system was recently shown to control metabolic functions by acting on peripheral tissues, such as adipocytes, hepatocytes, the gastrointestinal tract, and, possibly, skeletal muscle. The relevance of the system is further strenghtened by the notion that drugs interfering with the activity of the endocannabinoid system are considered as promising candidates for the treatment of various diseases, including obesity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
Grundy, S. M., Becker, D. M., Clark, L. T., Cooper, R., Denke, M. A., Howard, J. L., Hunninghake, D. B., Illingworth, D. R., Luepker, R. V., McBride, P. E., et al. (2002) · Civil War Book Review · Cited by 12,198
Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor
Devane, W. A., Hanuš, L., Breuer, A., Pertwee, R. G., Stevenson, L. A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A., & Mechoulam, R. (1992) · Science · doi:10.1126/science.1470919 · Cited by 5,633
Molecular characterization of a peripheral receptor for cannabinoids
Munro, S., Thomas, K. L., & Abu-Shaar, M. (1993) · Nature · doi:10.1038/365061a0 · Cited by 5,092 · cited 1×
“Two cannabinoid receptors have been identified and molecularly characterized so far, namely the seven transmembrane G protein-coupled cannabinoid receptor type 1 (CB1 receptor) (6) and type 2 (CB2 receptor) (7).”
BackgroundStructure of a cannabinoid receptor and functional expression of the cloned cDNA
Matsuda, L. A., Lolait, S. J., Brownstein, M. J., Young, A. C., & Bonner, T. I. (1990) · Nature · doi:10.1038/346561a0 · Cited by 5,011
What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience?
Berridge, K. C., & Robinson, T. E. (1998) · Brain Research Reviews · doi:10.1016/s0165-0173(98)00019-8 · Cited by 4,127
Ledent, C., Valverde, O., Cossu, G., Petitet, F., Aubert, J.-F., Beslot, F., Böhme, G. A., Imperato, A., Pedrazzini, T., Roques, B. P., et al. (1999) · Science · doi:10.1126/science.283.5400.401 · Cited by 3,614
Mechoulam, R., Ben-Shabat, S., Hanus, L., Ligumsky, M., Kaminski, N. E., Schatz, A. R., Gopher, A., Almog, S., Martin, B. R., Compton, D. R., et al. (1995) · Biochemical Pharmacology · doi:10.1016/0006-2952(95)00109-d · Cited by 2,913 · cited 1×
“Subsequently, a second endocannabinoid, 2-arachidonoyl glycerol (2-AG), was discovered (5, 9).”
BackgroundInternational Union of Pharmacology. XXVII. Classification of Cannabinoid Receptors
Howlett, A. C., Barth, F., Bonner, T. I., Cabral, G., Casellas, P., Devane, W. A., Felder, C. C., Herkenham, M., Mackie, K., Martin, B. R., et al. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.2.161 · Cited by 2,819
Isolation, Structure, and Partial Synthesis of an Active Constituent of Hashish
Gaoni, Y., & Mechoulam, R. (1964) · Journal of the American Chemical Society · doi:10.1021/ja01062a046 · Cited by 2,393
Cannabinoid receptor localization in brain.
Herkenham, M., Lynn, A. B., Little, M. D., Johnson, M. R., Melvin, L. S., de Costa, B. R., & Rice, K. C. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.5.1932 · Cited by 2,321
2-Arachidonoylgylcerol: A Possible Endogenous Cannabinoid Receptor Ligand in Brain
Sugiura, T., Kondo, S., Sukagawa, A., Nakane, S., Shinoda, A., Itoh, K., Yamashita, A., & Waku, K. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.2437 · Cited by 2,196
Herkenham, M., Lynn, A., Johnson, M., Melvin, L., de Costa, B., & Rice, K. (1991) · The Journal of Neuroscience · doi:10.1523/jneurosci.11-02-00563.1991 · Cited by 2,159
The molecular logic of endocannabinoid signalling
Piomelli, D. (2003) · Nature Reviews Neuroscience · doi:10.1038/nrn1247 · Cited by 1,957
SR141716A, a potent and selective antagonist of the brain cannabinoid receptor
Rinaldi-Carmona, M., Barth, F., Héaulme, M., Shire, D., Calandra, B., Congy, C., Martinez, S., Maruani, J., Néliat, G., Caput, D., et al. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)00773-x · Cited by 1,757
Galiègue, S., Mary, S., Marchand, J., Dussossoy, D., Carrière, D., Carayon, P., Bouaboula, M., Shire, D., LE Fur, G., & Casellas, P. (1995) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1995.tb20780.x · Cited by 1,749
The endogenous cannabinoid system controls extinction of aversive memories
Marsicano, G., Wotjak, C. T., Azad, S. C., Bisogno, T., Rammes, G., Cascio, M. G., Hermann, H., Tang, J., Hofmann, C., Zieglgänsberger, W., et al. (2002) · Nature · doi:10.1038/nature00839 · Cited by 1,728
Self-citationImmunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system
Tsou, K., Brown, S., Sañudo-Peña, M. C., Mackie, K., & Walker, J. M. (1998) · Neuroscience · doi:10.1016/s0306-4522(97)00436-3 · Cited by 1,586
Role of Endogenous Cannabinoids in Synaptic Signaling
FREUND, T. F., KATONA, I., & PIOMELLI, D. (2003) · Physiological Reviews · doi:10.1152/physrev.00004.2003 · Cited by 1,574
Leptin-regulated endocannabinoids are involved in maintaining food intake
Di Marzo, V., Goparaju, S. K., Wang, L., Liu, J., Bátkai, S., Járai, Z., Fezza, F., Miura, G. I., Palmiter, R. D., Sugiura, T., et al. (2001) · Nature · doi:10.1038/35071088 · Cited by 1,559 · cited 1×
“targeted by endocannabinoid action (58, 294).”
Van Gaal, L. F., Rissanen, A. M., Scheen, A. J., Ziegler, O., & Rössner, S. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66374-x · Cited by 1,499
Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia
Després, J.-P., Golay, A., & Sjöström, L. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa044537 · Cited by 1,392
Brain monoglyceride lipase participating in endocannabinoid inactivation
Dinh, T. P., Carpenter, D., Leslie, F. M., Freund, T. F., Katona, I., Sensi, S. L., Kathuria, S., & Piomelli, D. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.152334899 · Cited by 1,373 · cited 1×
“They are fatty acid amide hydrolase (FAAH) for anandamide and related compounds (96) and monoglycerol lipase for 2-AG (97), although other enzymes might be partially involved in the degradation of this last compound (98).”
BackgroundModulation of anxiety through blockade of anandamide hydrolysis
Kathuria, S., Gaetani, S., Fegley, D., Valiño, F., Duranti, A., Tontini, A., Mor, M., Tarzia, G., Rana, G. L., Calignano, A., et al. (2003) · Nature Medicine · doi:10.1038/nm803 · Cited by 1,293
Endocannabinoid Signaling in the Brain
Wilson, R. I., & Nicoll, R. A. (2002) · Science · doi:10.1126/science.1063545 · Cited by 1,260
Katona, I., Sperlágh, B., Sı́k, A., Käfalvi, A., Vizi, E. S., Mackie, K., & Freund, T. F. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-11-04544.1999 · Cited by 1,218
CB1 Cannabinoid Receptors and On-Demand Defense Against Excitotoxicity
Marsicano, G., Goodenough, S., Monory, K., Hermann, H., Eder, M., Cannich, A., Azad, S. C., Cascio, M. G., Gutiérrez, S. O., van der Stelt, M., et al. (2003) · Science · doi:10.1126/science.1088208 · Cited by 1,208
Self-citationBiological, Physiological, Pathophysiological, and Pharmacological Aspects of Ghrelin
van der Lely, A. J., Tschöp, M., Heiman, M. L., & Ghigo, E. (2004) · Endocrine Reviews · doi:10.1210/er.2002-0029 · Cited by 1,187
Cota, D., Marsicano, G., Tschöp, M., Grübler, Y., Flachskamm, C., Schubert, M., Auer, D., Yassouridis, A., Thöne-Reineke, C., Ortmann, S., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17725 · Cited by 1,168
Self-citationFlier, J. S. (2004) · Cell · doi:10.1016/s0092-8674(03)01081-x · Cited by 1,112
Osei-Hyiaman, D., DePetrillo, M., Pacher, P., Liu, J., Radaeva, S., Bátkai, S., Harvey-White, J., Mackie, K., Offertáler, L., Wang, L., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200523057 · Cited by 1,101
The endocannabinoid system and its therapeutic exploitation
Marzo, V. D., Bifulco, M., & Petrocellis, L. D. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1495 · Cited by 1,090
Cardiovascular Risk and Body-Fat Abnormalities in HIV-Infected Adults
Grinspoon, S., & Carr, A. (2005) · New England Journal of Medicine · doi:10.1056/nejmra041811 · Cited by 1,070
Fu, J., Gaetani, S., Oveisi, F., Lo Verme, J., Serrano, A., Rodríguez de Fonseca, F., Rosengarth, A., Luecke, H., Di Giacomo, B., Tarzia, G., et al. (2003) · Nature · doi:10.1038/nature01921 · Cited by 1,064
Control of pain initiation by endogenous cannabinoids
Calignano, A., Rana, G. L., Giuffrida, A., & Piomelli, D. (1998) · Nature · doi:10.1038/28393 · Cited by 1,056
Glass, M., Faull, R. L. M., & Dragunow, M. (1997) · Neuroscience · doi:10.1016/s0306-4522(96)00428-9 · Cited by 1,052
Sensitivity to leptin and susceptibility to seizures of mice lacking neuropeptide Y
Erickson, J. C., Clegg, K. E., & Palmiter, R. D. (1996) · Nature · doi:10.1038/381415a0 · Cited by 1,008
Adiponectin: More Than Just Another Fat Cell Hormone?
Chandran, M., Phillips, S. A., Ciaraldi, T., & Henry, R. R. (2003) · Diabetes Care · doi:10.2337/diacare.26.8.2442 · Cited by 1,008
Reduced Food Intake and Body Weight in Mice Treated with Fatty Acid Synthase Inhibitors
Loftus, T. M., Jaworsky, D. E., Frehywot, G. L., Townsend, C. A., Ronnett, G. V., Lane, M. D., & Kuhajda, F. P. (2000) · Science · doi:10.1126/science.288.5475.2379 · Cited by 1,004
The dopamine hypothesis of reward: past and current status
Spanagel, R., & Weiss, F. (1999) · Trends in Neurosciences · doi:10.1016/s0166-2236(99)01447-2 · Cited by 973
Huang, S. M., Bisogno, T., Trevisani, M., Al-Hayani, A., De Petrocellis, L., Fezza, F., Tognetto, M., Petros, T. J., Krey, J. F., Chu, C. J., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.122196999 · Cited by 964
Marsicano, G., & Lutz, B. (1999) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1999.00847.x · Cited by 937
Self-citationFunctional Role of High-Affinity Anandamide Transport, as Revealed by Selective Inhibition
Beltramo, M., Stella, N., Calignano, A., Lin, S. Y., Makriyannis, A., & Piomelli, D. (1997) · Science · doi:10.1126/science.277.5329.1094 · Cited by 813
Di, S., Malcher-Lopes, R., Halmos, K. C., & Tasker, J. G. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-12-04850.2003 · Cited by 801
Kirkham, T. C., Williams, C. M., Fezza, F., & Marzo, V. D. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704767 · Cited by 788
Hall, W., & Solowij, N. (1998) · The Lancet · doi:10.1016/s0140-6736(98)05021-1 · Cited by 772
2-Arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB 1 receptor
Hanuš, L., Abu-Lafi, S., Fride, E., Breuer, A., Vogel, Z., Shalev, D. E., Kustanovich, I., & Mechoulam, R. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.061029898 · Cited by 762
An endogenous cannabinoid (2-AG) is neuroprotective after brain injury
Panikashvili, D., Simeonidou, C., Ben-Shabat, S., Hanuš, L., Breuer, A., Mechoulam, R., & Shohami, E. (2001) · Nature · doi:10.1038/35097089 · Cited by 752
Endocannabinoids: endogenous cannabinoid receptor ligands with neuromodulatory action
Di Marzo, V., Melck, D., Bisogno, T., & De Petrocellis, L. (1998) · Trends in Neurosciences · doi:10.1016/s0166-2236(98)01283-1 · Cited by 712
An anorexic lipid mediator regulated by feeding
Rodríguez de Fonseca, F., Navarro, M., Gómez, R., Escuredo, L., Nava, F., Fu, J., Murillo-Rodríguez, E., Giuffrida, A., LoVerme, J., Gaetani, S., et al. (2001) · Nature · doi:10.1038/35102582 · Cited by 694
Molecular cloning of a human cannabinoid receptor which is also expressed in testis
Gérard, C. M., Mollereau, C., Vassart, G., & Parmentier, M. (1991) · Biochemical Journal · doi:10.1042/bj2790129 · Cited by 687
Activation of the peripheral endocannabinoid system in human obesity
Engeli, S., Böhnke, J., Feldpausch, M., Gorzelniak, K., Janke, J., Bátkai, S., Pacher, P., Harvey-White, J., Luft, F. C., Sharma, A. M., et al. (2005) · Diabetes · doi:10.2337/diabetes.54.10.2838 · Cited by 686 · cited 5×
“In such a context, a recent work (60) showed increased circulating levels of AEA and 2-AG in obese women when compared with a lean control group.”
BackgroundInfluentialNonpsychotropic Cannabinoid Receptors Regulate Microglial Cell Migration
Walter, L., Franklin, A., Witting, A., Wade, C., Xie, Y., Kunos, G., Mackie, K., & Stella, N. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-04-01398.2003 · Cited by 665
Glass, M., & Felder, C. C. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-14-05327.1997 · Cited by 635
Localization of cannabinoid receptor mRNA in rat brain
Matsuda, L. A., Bonner, T. I., & Lolait, S. J. (1993) · Journal of Comparative Neurology · doi:10.1002/cne.903270406 · Cited by 631 · cited 2×
“pothalamus, CB1 receptor is present in scattered cells (34, 36).”
BackgroundHernandez, L., & Hoebel, B. G. (1988) · Life Sciences · doi:10.1016/0024-3205(88)90036-7 · Cited by 627
Porter, A. C., Sauer, J.-M., Knierman, M. D., Becker, G. W., Berna, M. J., Bao, J., Nomikos, G. G., Carter, P., Bymaster, F. P., Leese, A. B., et al. (2002) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.301.3.1020 · Cited by 615
Shen, M., Piser, T. M., Seybold, V. S., & Thayer, S. A. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-14-04322.1996 · Cited by 604
Retrograde signaling in the regulation of synaptic transmission: focus on endocannabinoids
E. Alger, B. (2002) · Progress in Neurobiology · doi:10.1016/s0301-0082(02)00080-1 · Cited by 598
Arnone, M., Maruani, J., Chaperon, F., Thiébot, M.-H., Poncelet, M., Soubrié, P., & Fur, G. L. (1997) · Psychopharmacology · doi:10.1007/s002130050326 · Cited by 594
Bensaid, M., Gary-Bobo, M., Esclangon, A., Maffrand, J. P., Le Fur, G., Oury-Donat, F., & Soubrié, P. (2003) · Molecular Pharmacology · doi:10.1124/mol.63.4.908 · Cited by 593
Ravinet Trillou, C., Delgorge, C., Menet, C., Arnone, M., & Soubrié, P. (2004) · International Journal of Obesity · doi:10.1038/sj.ijo.0802583 · Cited by 583
HU-308: A specific agonist for CB 2 , a peripheral cannabinoid receptor
Hanuš, L., Breuer, A., Tchilibon, S., Shiloah, S., Goldenberg, D., Horowitz, M., Pertwee, R. G., Ross, R. A., Mechoulam, R., & Fride, E. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.25.14228 · Cited by 571
Anti-obesity effect of SR141716, a CB1 receptor antagonist, in diet-induced obese mice
Ravinet Trillou, C., Arnone, M., Delgorge, C., Gonalons, N., Keane, P., Maffrand, J.-P., & Soubrié, P. (2003) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00545.2002 · Cited by 566
Howlett, A. C. (2002) · Prostaglandins & Other Lipid Mediators · doi:10.1016/s0090-6980(02)00060-6 · Cited by 535
Cannabinoids control spasticity and tremor in a multiple sclerosis model
Baker, D., Pryce, G., Croxford, J. L., Brown, P., Pertwee, R. G., Huffman, J. W., & Layward, L. (2000) · Nature · doi:10.1038/35003583 · Cited by 532
The cannabinoid system and immune modulation
Klein, T. W., Newton, C., Larsen, K., Lu, L., Perkins, I., Nong, L., & Friedman, H. (2003) · Journal of Leukocyte Biology · doi:10.1189/jlb.0303101 · Cited by 524
Ibrahim, M. M., Porreca, F., Lai, J., Albrecht, P. J., Rice, F. L., Khodorova, A., Davar, G., Makriyannis, A., Vanderah, T. W., Mata, H. P., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409888102 · Cited by 521
Anandamide induces overeating: mediation by central cannabinoid (CB1) receptors
Williams, C. M., & Kirkham, T. C. (1999) · Psychopharmacology · doi:10.1007/s002130050953 · Cited by 505
Dronabinol as a treatment for anorexia associated with weight loss in patients with AIDS
Beal, J. E., Olson, R., Laubenstein, L., Morales, J. O., Bellman, P., Yangco, B., Lefkowitz, L., Plasse, T. F., & Shepard, K. V. (1995) · Journal of Pain and Symptom Management · doi:10.1016/0885-3924(94)00117-4 · Cited by 504
Appetite suppression and weight loss after the cannabinoid antagonist SR 141716
Colombo, G., Agabio, R., Diaz, G., Lobina, C., Reali, R., & Gessa, G. L. (1998) · Life Sciences · doi:10.1016/s0024-3205(98)00322-1 · Cited by 487
A Peripheral Mechanism for CB1 Cannabinoid Receptor-Dependent Modulation of Feeding
Gómez, R., Navarro, M., Ferrer, B., Trigo, J. M., Bilbao, A., Del Arco, I., Cippitelli, A., Nava, F., Piomelli, D., & Rodrı́guez de Fonseca, F. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-21-09612.2002 · Cited by 486
Huestis, M. A., Gorelick, D. A., Heishman, S. J., Preston, K. L., Nelson, R. A., Moolchan, E. T., & Frank, R. A. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.4.322 · Cited by 481
Melis, M., Pistis, M., Perra, S., Muntoni, A. L., Pillolla, G., & Gessa, G. L. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.4503-03.2004 · Cited by 478
The endocannabinoid system: a general view and latest additions
Petrocellis, L. D., Cascio, M. G., & Marzo, V. D. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705666 · Cited by 475
Patel, S., Roelke, C. T., Rademacher, D. J., Cullinan, W. E., & Hillard, C. J. (2004) · Endocrinology · doi:10.1210/en.2004-0638 · Cited by 475
Kola, B., Hubina, E., Tucci, S. A., Kirkham, T. C., Garcia, E. A., Mitchell, S. E., Williams, L. M., Hawley, S. A., Hardie, D. G., Grossman, A. B., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.c500175200 · Cited by 472
Anandamide administration into the ventromedial hypothalamus stimulates appetite in rats
Jamshidi, N., & Taylor, D. A. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704379 · Cited by 463
Bouaboula, M., Perrachon, S., Milligan, L., Canat, X., Rinaldi-Carmona, M., Portier, M., Barth, F., Calandra, B., Pecceu, F., Lupker, J., et al. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.35.22330 · Cited by 461
The endogenous cannabinoid system protects against colonic inflammation
Massa, F., Marsicano, G., Hermann, H., Cannich, A., Monory, K., Cravatt, B. F., Ferri, G.-L., Sibaev, A., Storr, M., & Lutz, B. (2004) · Journal of Clinical Investigation · doi:10.1172/jci19465 · Cited by 460
Self-citationSim, L. J., Selley, D. E., & Childers, S. R. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.16.7242 · Cited by 455
Depression of Plasma Testosterone Levels after Chronic Intensive Marihuana Use
Kolodny, R. C., Masters, W. H., Kolodner, R. M., & Toro, G. (1974) · New England Journal of Medicine · doi:10.1056/nejm197404182901602 · Cited by 452
Inverse agonism and neutral antagonism at cannabinoid CB1 receptors
Pertwee, R. G. (2005) · Life Sciences · doi:10.1016/j.lfs.2004.10.025 · Cited by 444
CB1 Cannabinoid Receptor Inhibits Synaptic Release of Glutamate in Rat Dorsolateral Striatum
Gerdeman, G., & Lovinger, D. M. (2001) · Journal of Neurophysiology · doi:10.1152/jn.2001.85.1.468 · Cited by 433
Wynne, K., Stanley, S., McGowan, B., & Bloom, S. (2005) · Journal of Endocrinology · doi:10.1677/joe.1.05866 · Cited by 430
Molecular characterization of human and mouse fatty acid amide hydrolases
Giang, D. K., & Cravatt, B. F. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.6.2238 · Cited by 429
Evidence for novel cannabinoid receptors
BEGG, M., PACHER, P., BATKAI, S., OSEIHYIAMAN, D., OFFERTALER, L., MO, F., LIU, J., & KUNOS, G. (2005) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2004.11.005 · Cited by 385
Antiemetic Effect of Delta-9-Tetrahydrocannabinol in Patients Receiving Cancer Chemotherapy
Sallan, S. E., Zinberg, N. E., & Frei, E. (1975) · New England Journal of Medicine · doi:10.1056/nejm197510162931603 · Cited by 364
Kearn, C. S., Blake-Palmer, K., Daniel, E., Mackie, K., & Glass, M. (2005) · Molecular Pharmacology · doi:10.1124/mol.104.006882 · Cited by 359
In silico patent searching reveals a new cannabinoid receptor
Baker, D., Pryce, G., Davies, W. L., & Hiley, C. R. (2006) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2005.11.003 · Cited by 348
De Petrocellis, L., Bisogno, T., Davis, J. B., Pertwee, R. G., & Di Marzo, V. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)02082-2 · Cited by 347
Egertová, M., Cravatt, B. F., & Elphick, M. R. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00145-3 · Cited by 347
Jbilo, O., Ravinet‐Trillou, C., Arnone, M., Buisson, I., Bribes, E., Péleraux, A., Pénarier, G., Soubrié, P., Le Fur, G., Galiègue, S., et al. (2005) · The FASEB Journal · doi:10.1096/fj.04-3177fje · Cited by 346
de Kloet, E. R. (2003) · PubMed · Cited by 338
Meltzer, H. Y., Arvanitis, L., Bauer, D., Rein, W., & Meta-Trial Study Group (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.6.975 · Cited by 330
Guzmán, M., Lo Verme, J., Fu, J., Oveisi, F., Blázquez, C., & Piomelli, D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m404087200 · Cited by 328
Cannabinoids and the gastrointestinal tract
PERTWEE, R. G. (2001) · Gut · doi:10.1136/gut.48.6.859 · Cited by 326
Endogenous cannabinoid system as a modulator of food intake
Cota, D., Marsicano, G., Lutz, B., Vicennati, V, Stalla, G. K., Pasquali, R., & Pagotto, U. (2003) · International Journal of Obesity · doi:10.1038/sj.ijo.0802250 · Cited by 315
Self-citationHashimotodani, Y., Ohno-Shosaku, T., Tsubokawa, H., Ogata, H., Emoto, K., Maejima, T., Araishi, K., Shin, H.-S., & Kano, M. (2005) · Neuron · doi:10.1016/j.neuron.2005.01.004 · Cited by 315
Liu, Y. L., Connoley, I. P., Wilson, C. A., & Stock, M. J. (2005) · International Journal of Obesity · doi:10.1038/sj.ijo.0802847 · Cited by 313
The endocannabinoid anandamide is a direct and selective blocker of the background K+ channel TASK-1
Maingret, F. (2001) · The EMBO Journal · doi:10.1093/emboj/20.1.47 · Cited by 313
Bisogno, T., Berrendero, F., Ambrosino, G., Cebeira, M., Ramos, J. A., Fernandez-Ruiz, J. J., & Di Marzo, V. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0254 · Cited by 312
Long-lasting self-inhibition of neocortical interneurons mediated by endocannabinoids
Bacci, A., Huguenard, J. R., & Prince, D. A. (2004) · Nature · doi:10.1038/nature02913 · Cited by 306
Navarro, M., Hernández, E., Muñoz, R. M., del Arco, I., Villanúa, M. A., Carrera, M. R. A., & Rodríguez de Fonseca, F. (1997) · NeuroReport · doi:10.1097/00001756-199701200-00023 · Cited by 306
Fatty acid amide hydrolase: an emerging therapeutic target in the endocannabinoid system
Cravatt, B. F., & Lichtman, A. H. (2003) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(03)00079-6 · Cited by 302
Endocannabinoid-Mediated Metaplasticity in the Hippocampus
Chevaleyre, V., & Castillo, P. E. (2004) · Neuron · doi:10.1016/j.neuron.2004.08.036 · Cited by 302
van der Stelt, M., & Di Marzo, V. (2003) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2003.08.101 · Cited by 291
Hermann, H., Marsicano, G., & Lutz, B. (2002) · Neuroscience · doi:10.1016/s0306-4522(01)00509-7 · Cited by 290
Self-citationWestlake, T. M., Howlett, A. C., Bonner, T. I., Matsuda, L. A., & Herkenham, M. (1994) · Neuroscience · doi:10.1016/0306-4522(94)90511-8 · Cited by 283
Chaperon, F., Soubrié, P., Puech, A. J., & Thiébot, M.-H. (1998) · Psychopharmacology · doi:10.1007/s002130050518 · Cited by 280
Expression of Cannabinoid CB1 Receptors by Vagal Afferent Neurons Is Inhibited by Cholecystokinin
Burdyga, G., Lal, S., Varro, A., Dimaline, R., Thompson, D. G., & Dockray, G. J. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.5404-03.2004 · Cited by 280
Expression of the CB1 and CB2 receptor messenger RNAs during embryonic development in the rat
Buckley, N. E., Hansson, S., Harta, G., & Mezey, É. (1997) · Neuroscience · doi:10.1016/s0306-4522(97)00348-5 · Cited by 265
Schmid, P. C., Paria, B. C., Krebsbach, R. J., Schmid, H. H. O., & Dey, S. K. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.8.4188 · Cited by 264
SR 141716, a CB1 cannabinoid receptor antagonist, selectively reduces sweet food intake in marmoset.
Simiand, J., Keane, M., Keane, P. E., & Soubrié, P. (1998) · PubMed · Cited by 264
Circuitry for associative plasticity in the amygdala involves endocannabinoid signaling
Azad, S. C., Monory, K., Marsicano, G., Cravatt, B. F., Lutz, B., Zieglgänsberger, W., & Rammes, G. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.2134-04.2004 · Cited by 263 · cited 1×
“For instance, electrophysiological and biochemical evidence shows that 2-AG is mostly involved in retrograde control of synaptic activity in the VTA (109), or the hippocampus (112), whereas AEA appears to play an important role in other regions, such as the basal ganglia (113) and the amygdala (114).”
BackgroundOverweight and obesity associated with a missense polymorphism in fatty acid amide hydrolase (FAAH)
Sipe, J. C., Waalen, J., Gerber, A., & Beutler, E. (2005) · International Journal of Obesity · doi:10.1038/sj.ijo.0802954 · Cited by 259
Hyperphagia in pre-fed rats following oral δ9-THC
Williams, C. M., Rogers, P. J., & Kirkham, T. C. (1998) · Physiology & Behavior · doi:10.1016/s0031-9384(98)00170-x · Cited by 256
Melis, M., Perra, S., Muntoni, A. L., Pillolla, G., Lutz, B., Marsicano, G., Di Marzo, V., Gessa, G. L., & Pistis, M. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.3502-04.2004 · Cited by 253
Self-citationGatley, S. J., Gifford, A. N., Volkow, N. D., Lan, R., & Makriyannis, A. (1996) · European Journal of Pharmacology · doi:10.1016/0014-2999(96)00279-8 · Cited by 252
Cannabinoid Transmission and Reward-Related Events
Gardner, E. L., & Vorel, S. R. (1998) · Neurobiology of Disease · doi:10.1006/nbdi.1998.0219 · Cited by 250
Rossato, M., Ion Popa, F., Ferigo, M., Clari, G., & Foresta, C. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1287 · Cited by 248
Anandamide acts as an intracellular messenger amplifying Ca2+ influx via TRPV1 channels
van der Stelt, M., Trevisani, M., Vellani, V., De Petrocellis, L., Schiano Moriello, A., Campi, B., McNaughton, P., Geppetti, P., & Di Marzo, V. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600784 · Cited by 245
Evaluation of CB1 Receptor Knockout Mice in the Morris Water Maze
Varvel, S. A., & Lichtman, A. H. (2002) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.301.3.915 · Cited by 244
Cleland, J. G. F., Ghosh, J., Freemantle, N., Kaye, G. C., Nasir, M., Clark, A. L., & Coletta, A. P. (2004) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2004.04.014 · Cited by 244
GABAergic interneurons are the targets of cannabinoid actions in the human hippocampus
Katona, I., Sperlágh, B., Maglóczky, Z., Sántha, E., Köfalvi, A., Czirják, S., Mackie, K., Vizi, E. S., & Freund, T. F. (2000) · Neuroscience · doi:10.1016/s0306-4522(00)00286-4 · Cited by 244
de Fonseca, F. R., Cebeira, M., Ramos, J. A., Martín, M., & Fernández-Ruiz, J. J. (1994) · Life Sciences · doi:10.1016/0024-3205(94)00585-0 · Cited by 243
Köfalvi, A., Rodrigues, R. J., Ledent, C., Mackie, K., Vizi, E. S., Cunha, R. A., & Sperlágh, B. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.4232-04.2005 · Cited by 242
Relation between decreased anandamide hydrolase concentrations in human lymphocytes and miscarriage
Maccarrone, M., Valensise, H., Bari, M., Lazzarin, N., Romanini, C., & Finazzi-Agrò, A. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02115-2 · Cited by 241
N-Acylethanolamines in human reproductive fluids
Schuel, H., Burkman, L. J., Lippes, J., Crickard, K., Forester, E., Piomelli, D., & Giuffrida, A. (2002) · Chemistry and Physics of Lipids · doi:10.1016/s0009-3084(02)00158-5 · Cited by 235
Felder, C. C., Joyce, K. E., Briley, E. M., Glass, M., Mackie, K. P., Fahey, K. J., Cullinan, G. J., Hunden, D. C., Johnson, D. W., Chaney, M. O., et al. (1998) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37189-7 · Cited by 233
Dinh, T. P., Kathuria, S., & Piomelli, D. (2004) · Molecular Pharmacology · doi:10.1124/mol.104.002071 · Cited by 229
Hao, S., Avraham, Y., Mechoulam, R., & Berry, E. M. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00059-5 · Cited by 229
Cannabinoids and brain injury: therapeutic implications
Mechoulam, R. (2002) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(02)02276-1 · Cited by 229
Increased Severity of Stroke in CB1 Cannabinoid Receptor Knock-Out Mice
Parmentier-Batteur, S., Jin, K., Mao, X. O., Xie, L., & Greenberg, D. A. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-22-09771.2002 · Cited by 225
Immunohistochemical localization of the neural cannabinoid receptor in rat brain
Pettit, D. A. D., Harrison, M. P., Olson, J. M., Spencer, R. F., & Cabral, G. A. (1998) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19980201)51:3<391::aid-jnr12>3.0.co;2-a · Cited by 224
Recent clinical experience with dronabinol
Plasse, T. F., Gorter, R. W., Krasnow, S. H., Lane, M., Shepard, K. V., & Wadleigh, R. G. (1991) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(91)90385-f · Cited by 224
Cannabinoid signaling in glial cells
Stella, N. (2004) · Glia · doi:10.1002/glia.20084 · Cited by 219
Impaired action of anxiolytic drugs in mice deficient in cannabinoid CB1 receptors
Urigüen, L., Pérez-Rial, S., Ledent, C., Palomo, T., & Manzanares, J. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.01.003 · Cited by 218
Aberrant cannabinoid signaling impairs oviductal transport of embryos
Wang, H., Guo, Y., Wang, D., Kingsley, P. J., Marnett, L. J., Das, S. K., DuBois, R. N., & Dey, S. K. (2004) · Nature Medicine · doi:10.1038/nm1104 · Cited by 217
Beal, J. E., Olson, R., Lefkowitz, L., Laubenstein, L., Bellman, P., Yangco, B., Morales, J. O., Murphy, R., Powderly, W., Plasse, T. F., et al. (1997) · Journal of Pain and Symptom Management · doi:10.1016/s0885-3924(97)00038-9 · Cited by 206
The endogenous cannabinoid system and its role in nociceptive behavior
Cravatt, B. F., & Lichtman, A. H. (2004) · Journal of Neurobiology · doi:10.1002/neu.20080 · Cited by 203
The anti‐obesity effect of rimonabant is associated with an improved serum lipid profile
Poirier, B., Bidouard, J. ‐., Cadrouvele, C., Marniquet, X., Staels, B., O'Connor, S. E., Janiak, P., & Herbert, J. ‐. (2005) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2004.00374.x · Cited by 203
Buyse, M., Ovesjö, M., Goïot, H., Guilmeau, S., Péranzi, G., Moizo, L., Walker, F., Lewin, M. J. M., Meister, B., & Bado, A. (2001) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2001.01628.x · Cited by 203
Vickers, S. P., Dourish, C. T., & Kennett, G. A. (2001) · Neuropharmacology · doi:10.1016/s0028-3908(01)00063-6 · Cited by 202
The preimplantation mouse embryo is a target for cannabinoid ligand-receptor signaling.
Paria, B. C., Das, S. K., & Dey, S. K. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.21.9460 · Cited by 200
The Functional Neuroanatomy of Brain Cannabinoid Receptors
Breivogel, C. S., & Childers, S. R. (1998) · Neurobiology of Disease · doi:10.1006/nbdi.1998.0229 · Cited by 197
Sugiura, T., Kondo, S., Sukagawa, A., Tonegawa, T., Nakane, S., Yamashita, A., & Waku, K. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.0020 · Cited by 197
González, S., Bisogno, T., Wenger, T., Manzanares, J., Milone, A., Berrendero, F., Di Marzo, V., Ramos, J. A., & Fernández-Ruiz, J. J. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.2406 · Cited by 197
The motivation for beer in rats: effects of ritanserin, naloxone and SR 141716
Gallate, J. E., & McGregor, I. S. (1999) · Psychopharmacology · doi:10.1007/s002130050893 · Cited by 195
Observational analysis of feeding induced by Δ9-THC and anandamide
WILLIAMS, C., & KIRKHAM, T. (2002) · Physiology & Behavior · doi:10.1016/s0031-9384(02)00725-4 · Cited by 194
Feeding induced by opioid stimulation of the ventral striatum: role of opiate receptor subtypes.
Bakshi, V. P., & Kelley, A. E. (1993) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)38247-9 · Cited by 193
Hypersensitization of the Orexin 1 Receptor by the CB1 Receptor
Hilairet, S., Bouaboula, M., Carrière, D., Le Fur, G., & Casellas, P. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212369200 · Cited by 190
Lange, J. H. M., Coolen, H. K. A. C., van Stuivenberg, H. H., Dijksman, J. A. R., Herremans, A. H. J., Ronken, E., Keizer, H. G., Tipker, K., McCreary, A. C., Veerman, W., et al. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm031019q · Cited by 189
Breivogel, C. S., Selley, D. E., & Childers, S. R. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.27.16865 · Cited by 185
Tucci, S. A., Rogers, E. K., Korbonits, M., & Kirkham, T. C. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705968 · Cited by 183
Psychopharmacological activity of the active constituents of hashish and some related cannabinoids
Grunfeld, Y., & Edery, H. (1969) · Psychopharmacologia · doi:10.1007/bf00404218 · Cited by 182
Hildebrandt, A. L., Kelly-Sullivan, D. M., & Black, S. C. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(03)01343-8 · Cited by 181
CB1 cannabinoid receptors are involved in neuroprotection via NF-κB inhibition
Panikashvili, D., Mechoulam, R., Beni, S. M., Alexandrovich, A., & Shohami, E. (2005) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600047 · Cited by 181
Cannabinoid ligand-receptor signaling in the mouse uterus.
Das, S. K., Paria, B. C., Chakraborty, I., & Dey, S. K. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.10.4332 · Cited by 179
Weidenfeld, J., Feldman, S., & Mechoulam, R. (1994) · Neuroendocrinology · doi:10.1159/000126646 · Cited by 177
Function of Cannabinoid Receptors in the Neuroendocrine Regulation of Hormone Secretion
Murphy, L. L., Muñoz, R. M., Adrian, B. A., & Villanúa, M. A. (1998) · Neurobiology of Disease · doi:10.1006/nbdi.1998.0224 · Cited by 176
Behavioral analysis of marijuana effects on food intake in humans
Foltin, R. W., Brady, J. V., & Fischman, M. W. (1986) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(86)90144-9 · Cited by 176
Cannabinoid effects on anxiety-related behaviours and hypothalamic neurotransmitters
Arévalo, C., de Miguel, R., & Hernández-Tristán, R. (2001) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00578-0 · Cited by 175
Rodríguez de Fonseca, F., Rubio, P., Menzaghi, F., Merlo-Pich, E., Rivier, J., Koob, G. F., & Navarro, M. (1996) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12276-3 · Cited by 175
Oleamide is a selective endogenous agonist of rat and human CB1 cannabinoid receptors
Leggett, J. D., Aspley, S., Beckett, S. R. G., D'Antona, A. M., Kendall, D. A., & Kendall, D. A. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705607 · Cited by 174
The Central Cannabinoid Receptor Inactivation Suppresses Endocrine Reproductive Functions
Wenger, T., Ledent, C., Csernus, V., & Gerendai, I. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.4977 · Cited by 172
Schuel, H., Goldstein, E., Mechoulam, R., Zimmerman, A. M., & Zimmerman, S. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.16.7678 · Cited by 172
Targeting the endocannabinoid system in cancer therapy: A call for further research
Bifulco, M., & Di Marzo, V. (2002) · Nature Medicine · doi:10.1038/nm0602-547 · Cited by 172
Anandamide induces necrosis in primary hepatic stellate cells†‡
Siegmund, S. V., Uchinami, H., Osawa, Y., Brenner, D. A., & Schwabe, R. F. (2005) · Hepatology · doi:10.1002/hep.20667 · Cited by 171
Endogenous cannabinoids and appetite
Kirkham, T. C., & Williams, C. M. (2001) · Nutrition Research Reviews · doi:10.1079/095442201108729141 · Cited by 171
Chronic Stress‐Induced Effects of Corticosterone on Brain: Direct and Indirect
DALLMAN, M. F., AKANA, S. F., STRACK, A. M., SCRIBNER, K. S., PECORARO, N., LA FLEUR, S. E., HOUSHYAR, H., & GOMEZ, F. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1296.017 · Cited by 167
Higgs, S., Williams, C. M., & Kirkham, T. C. (2003) · Psychopharmacology · doi:10.1007/s00213-002-1263-3 · Cited by 165
The expanding field of cannabimimetic and related lipid mediators
Bradshaw, H. B., & Walker, J. M. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706093 · Cited by 163
Synergistic efects of opioid and cannabinoid antagonists on food intake
Kirkham, T. C., & Williams, C. M. (2001) · Psychopharmacology · doi:10.1007/s002130000596 · Cited by 162
De Petrocellis, L., Melck, D., Bisogno, T., Milone, A., & Di Marzo, V. (1999) · Neuroscience · doi:10.1016/s0306-4522(98)00749-0 · Cited by 161
Paria, B. C., & Dey, S. K. (2000) · Chemistry and Physics of Lipids · doi:10.1016/s0009-3084(00)00197-3 · Cited by 161
Reversal of Δ9-THC hyperphagia by SR141716 and naloxone but not dexfenfluramine
Williams, C. M., & Kirkham, T. C. (2002) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00694-3 · Cited by 158
Cannabis: Effects on hunger and thirst
Abel, E. L. (1975) · Behavioral Biology · doi:10.1016/s0091-6773(75)91684-3 · Cited by 157
Harrold, J. A., Elliott, J. C., King, P., Widdowson, P. S., & Williams, G. (2002) · Brain Research · doi:10.1016/s0006-8993(02)03245-6 · Cited by 156
Pagotto, U., Marsicano, G., Fezza, F., Theodoropoulou, M., Grübler, Y., Stalla, J., Arzberger, T., Milone, A., Losa, M., Marzo, V. D., et al. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.6.7565 · Cited by 153
Self-citationWang, H., Matsumoto, H., Guo, Y. X., Paria, B. C., Roberts, R. L., & Dey, S. K. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2436379100 · Cited by 152
Endocannabinoids and Neuroprotection
Mechoulam, R., Spatz, M., & Shohami, E. (2002) · Science Signaling · doi:10.1126/stke.2002.129.re5 · Cited by 151
Paria, B. C., Deutsch, D. D., & Dey, S. K. (1996) · Molecular Reproduction and Development · doi:10.1002/(sici)1098-2795(199610)45:2<183::aid-mrd11>3.0.co;2-2 · Cited by 149
Evans, C.-O., Young, A. N., Brown, M. R., Brat, D. J., Parks, J. S., Neish, A. S., & Oyesiku, N. M. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.7.7616 · Cited by 145
Evidence that anandamide‐signaling regulates human sperm functions required for fertilization
Schuel, H., Burkman, L. J., Lippes, J., Crickard, K., Mahony, M. C., Giuffrida, A., Picone, R. P., & Makriyannis, A. (2002) · Molecular Reproduction and Development · doi:10.1002/mrd.90021 · Cited by 145
Rowland, N. E., Mukherjee, M., & Robertson, K. (2001) · Psychopharmacology · doi:10.1007/s002130100910 · Cited by 144
Barnett‐Norris, J., Lynch, D. L., & Reggio, P. H. (2005) · Life Sciences · doi:10.1016/j.lfs.2005.05.040 · Cited by 143
Effects of SR141716A, a central cannabinoid receptor antagonist, on food-maintained responding
Freedland, C. S., Poston, J. S., & Porrino, L. J. (2000) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(00)00359-2 · Cited by 141
A Role for Caveolae/Lipid Rafts in the Uptake and Recycling of the Endogenous Cannabinoid Anandamide
McFarland, M. J., Porter, A. C., Rakhshan, F., Rawat, D. S., Gibbs, R. A., & Barker, E. L. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m407250200 · Cited by 139
Barna, I., Zelena, D., Arszovszki, A. C., & Ledent, C. (2004) · Life Sciences · doi:10.1016/j.lfs.2004.06.006 · Cited by 136 · cited 1×
“and CRH-stimulated dispersed pituitary cells or isolated pituitary slices, respectively (135, 142).”
BackgroundCani, P. D., Montoya, M. L., Neyrinck, A. M., Delzenne, N. M., & Lambert, D. M. (2004) · British Journal Of Nutrition · doi:10.1079/bjn20041256 · Cited by 136
Study of cannabinoid dependence in animals
Maldonado, R. J. (2002) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(02)00254-1 · Cited by 136
Expression of FAS within hypothalamic neurons: a model for decreased food intake after C75 treatment
Kim, E. K., Miller, I., Landree, L. E., Borisy-Rudin, F. F., Brown, P., Tihan, T., Townsend, C. A., Witters, L. A., Moran, T. H., Kuhajda, F. P., et al. (2002) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00178.2002 · Cited by 131
Critical role of the endogenous cannabinoid system in mouse pup suckling and growth
Fride, E., Ginzburg, Y., Breuer, A., Bisogno, T., Marzo, V. D., & Mechoulam, R. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)00953-0 · Cited by 129
Short-term fasting and prolonged semistarvation have opposite effects on 2-AG levels in mouse brain
Hanus, L. O., Avraham, Y., Ben‐Shushan, D., Zolotarev, O., Berry, E. M., & Mechoulam, R. (2003) · Brain Research · doi:10.1016/s0006-8993(03)03046-4 · Cited by 127
de Fonseca, F. R., Cebeira, M., Fernández‐Ruíz, J., Navarro, M. A., & Ramos, J. A. (1991) · Neuroscience · doi:10.1016/0306-4522(91)90329-m · Cited by 126
l - Δ 9 - trans -Tetrahydrocannabinol in Pigeons: Tolerance to the Behavioral Effects
McMillan, D. E., Harris, L. S., Frankenheim, J., & Kennedy, J. S. (1970) · Science · doi:10.1126/science.169.3944.501 · Cited by 123
Park, B., Gibbons, H. M., Mitchell, M. D., & Glassa, M. (2003) · Placenta · doi:10.1053/plac.2002.0926 · Cited by 122
Comparison of acute oral toxicity of cannabinoids in rats, dogs and monkeys
Thompson, G. R., Rosenkrantz, H., Schaeppi, U. H., & Braude, M. C. (1973) · Toxicology and Applied Pharmacology · doi:10.1016/0041-008x(73)90310-4 · Cited by 121
Behavioral Effects in Monkeys of Racemates of Two Biologically Active Marijuana Constituents
Scheckel, C. L., Boff, E., Dahlen, P., & Smart, T. (1968) · Science · doi:10.1126/science.160.3835.1467 · Cited by 120
Cited by
The Endocannabinoid System as an Emerging Target of Pharmacotherapy
Pacher, P., Bátkai, S., & Kunos, G. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.3.2 · Cited by 2,077
“This subject has been the topic of a number of recent reviews (Di Marzo and Matias, 2005; Kirkham, 2005; Sharkey and Pittman, 2005; Pagotto et al., 2006), and only a brief summary is provided here.”
BackgroundEndocannabinoid-Mediated Control of Synaptic Transmission
Kano, M., Ohno-Shosaku, T., Hashimotodani, Y., Uchigashima, M., & Watanabe, M. (2009) · Physiological Reviews · doi:10.1152/physrev.00019.2008 · Cited by 1,529
Wu, F. C. W., Tajar, A., Pye, S. R., Silman, A. J., Finn, J. D., O'Neill, T. W., Bartfai, G., Casanueva, F., Forti, G., Giwercman, A., et al. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1972 · Cited by 939
Childhood maltreatment and obesity: systematic review and meta-analysis
Danese, A., & Tan, M. (2014) · Molecular Psychiatry · doi:10.1038/mp.2013.54 · Cited by 709
Endocannabinoid signaling at the periphery: 50 years after THC
Maccarrone, M., Bab, I., Bíró, T., Cabral, G. A., Dey, S. K., Di Marzo, V., Konje, J. C., Kunos, G., Mechoulam, R., Pacher, P., et al. (2015) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2015.02.008 · Cited by 646
Metadata
- Authors
- Pagotto, U., Marsicano, G., Cota, D., Lutz, B., & Pasquali, R.
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2005-11-23
- Volume
- 27
- Issue
- 1
- Pages
- 73-100
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- OpenAlex
- W2122487138
- Cited by
- 865
- References
- 295
- FWCI
- 38.82
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.